Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Tg Therapeuticscmn (TGTX)

Tg Therapeuticscmn (TGTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Why TG Therapeutics Stock Was Rocketing Higher This Week Motley Fool - Fri May 3, 4:56AM CDT

The company raised guidance for sales of its drug for relapsing multiple sclerosis.

TGTX : 16.19 (-1.40%)
TG Therapeutics: Q1 Earnings Snapshot AP - Wed May 1, 6:32AM CDT

TG Therapeutics: Q1 Earnings Snapshot

TGTX : 16.19 (-1.40%)
TG Therapeutics: Q4 Earnings Snapshot AP - Wed Feb 28, 6:32AM CST

TG Therapeutics: Q4 Earnings Snapshot

TGTX : 16.19 (-1.40%)
Why TG Therapeutics Stock Is Crushing It Today Motley Fool - Wed Nov 1, 2023

The biopharmaceutical company's Q3 update was music to investors' ears.

TGTX : 16.19 (-1.40%)
TG Therapeutics: Q3 Earnings Snapshot AP - Wed Nov 1, 2023

TG Therapeutics: Q3 Earnings Snapshot

TGTX : 16.19 (-1.40%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of TG Therapeutics, Inc. - TGTX PR Newswire - Wed Sep 13, 2023

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of TG Therapeutics, Inc. ("TG Therapeutics" or the "Company") (NASDAQ: TGTX). Such...

TGTX : 16.19 (-1.40%)
Why TG Therapeutics Stock Is Crashing Today Motley Fool - Tue Aug 1, 2023

The drugmaker delivered a couple of surprises in Q2.

TGTX : 16.19 (-1.40%)
TG Therapeutics: Q2 Earnings Snapshot AP - Tue Aug 1, 2023

TG Therapeutics: Q2 Earnings Snapshot

TGTX : 16.19 (-1.40%)
Why Apellis Pharmaceuticals, TG Therapeutics, and Viking Therapeutics Were on the Move Today Motley Fool - Mon May 1, 2023

These three biotech stocks were on the volatile side today.

APLS : 47.46 (-0.06%)
TGTX : 16.19 (-1.40%)
VKTX : 76.97 (+1.60%)
ISEE : 39.95 (+0.38%)
ALPMY : 10.0400 (+0.70%)
TG Therapeutics (TGTX) Reports Q1 Loss, Tops Revenue Estimates Zacks - Mon May 1, 2023

TG Therapeutics (TGTX) delivered earnings and revenue surprises of 22.22% and 105.94%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

TGTX : 16.19 (-1.40%)
ICUI : 99.99 (+0.96%)

Barchart Exclusives

Earnings, the Yen and Other Key Things to Watch This Week Barchart - Sun May 5, 2:00PM CDT
This week is relatively quiet on the news front, but there are still earnings due out and plenty of other macro factors to watch. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot